Langerhans Cell Histiocytosis Caused by Adalimumab for Crohn’s Disease: A Case Report
Keywords:Langerhans cell histiocytosis, adalimumab, paradoxical reaction
Abstract is missing (Short communication)
Windebank K, Nanduri V. Langerhans cell histiocytosis. Arch Dis Child 2009; 94: 904-908.
Allen CE, Merad M, McClain KL. Langerhans-cell histiocytosis. N Engl J Med 2018; 379: 856-868.
Kobayashi M, Tojo A. Langerhans cell histiocytosis in adults: advances in pathophysiology and treatment. Cancer Science 2018; 109: 3707-3713.
Shahidi-Dadras M, Saeedi M, Shakoei S, Ayatollahi A. Langerhans cell histiocytosis: an uncommon presentation, successfully treated by thalidomide. Indian J Dermatol Venereol Leprol 2011; 77: 587-590.
McClain KL, Kozinetz CA. A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer 2007; 48: 44-49.
Seneschal J, Milpied B, Vergier B, Lepreux S, Schaeverbeke T, Taïeb A. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 2009; 161: 1081-1088.
Rodriguez HN, García I, Alba A, Igea F. Inﬂiximab-induced reactivated Langerhan's cell hstiocytosis in a patient with ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1286-1287.
Podjasek JO, Loftus CG, Smyrk TC, Wieland CN. Adult-onset systemic Langerhans cell histiocytosis mimicking inflammatory bowel disease: the value of skin biopsy and review of cases of Langerhans cell histiocytosis with cutaneous involvement seen at the Mayo Clinic. Int J Dermatol 2014; 53: 305-311.
Therrien A, El Haffaf Z, Wartelle-Bladou C, Côté-Daigneault J, Nguyen BN. Langerhans cell histiocytosis presenting as Crohn's disease: a case report. Int J Colorectal Dis 2018; 33: 1501-1504.
Kvedaraite E, Lourda M, Han H, Tesi B, Mitchell J, Ideström M et al. Patients with both Langerhans cell histiocytosis and Crohn's disease highlight a common role of interleukin-23. Acta Paediatr 2021; 110: 1315-1321.
How to Cite
Copyright (c) 2023 Mariko Kochi, Tetsuya Higuchi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.